Albumin for bleeding from liver veins
Treatments studied
Part of Blood & lymphatic, Digestive system clinical trials.
This trial tests whether giving a protein called albumin along with standard care can improve outcomes for people with cirrhosis who are actively bleeding from swollen veins in their esophagus or stomach. If you qualify, you might receive extra albumin to help your body cope with the bleeding and possibly reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult between 18 and 70 years old.
- You have been diagnosed with cirrhosis (liver scarring) and are currently having bleeding from enlarged veins in your esophagus or stomach.
- You do not have a blood clot in the portal vein (the vein carrying blood from the intestines to the liver).
- You do not have liver cancer, heart failure, or chronic kidney disease.
- You have not received albumin (a blood protein) in the last month and you do not need fresh frozen plasma (a blood product).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving tranexamic acid and vitamin K by injection can help control bleeding from the upper digestive tract in people with liver cirrhosis. It may offer a way to stop bleeding more quickly.
This study tests whether giving albumin (a protein) along with water pills helps reduce leg swelling in people with cirrhosis and ascites. It may be an option if your leg swelling hasn't improved with standard diuretics alone.
This study compares two treatments for bleeding stomach varices (swollen veins) in people with cirrhosis. One uses a special scope with ultrasound to place coils and glue, while the other uses glue alone. The goal is to find which works better to stop bleeding.
This Phase 2 trial tests whether giving albumin together with enoxaparin (a blood thinner) can improve outcomes for people hospitalized with decompensated cirrhosis who are at high risk. It may help your recovery after certain serious liver-related complications and reduce the chance of poor outcomes.
This trial tests whether a personalized long-term albumin (a blood protein medicine) can help people with advanced liver scarring who have fluid in the belly (ascites). It compares the personalized albumin approach to standard care to see if it improves outcomes over time.
This study tests whether giving albumin through a vein helps people with cirrhosis who have a certain type of kidney problem (called acute kidney injury). The goal is to see if albumin works better than a simple saltwater solution in improving kidney function.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.